NewGenIvf Group Stock Scheduled to Reverse Split on Monday, July 6th (NASDAQ:NIVF)

Shares of NewGenIvf Group Limited (NASDAQ:NIVF) are going to reverse split on Monday, July 6th. The 1-3 reverse split was recently announced. The number of shares owned by shareholders will be adjusted after the closing bell on Sunday, July 5th.

NewGenIvf Group Stock Down 16.4%

Shares of NewGenIvf Group stock traded down $0.09 during trading on Thursday, hitting $0.46. 876,271 shares of the company’s stock were exchanged, compared to its average volume of 11,033,116. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16. The business has a 50-day simple moving average of $0.97 and a 200-day simple moving average of $3.34. NewGenIvf Group has a 52-week low of $0.43 and a 52-week high of $295.17.

NewGenIvf Group (NASDAQ:NIVF) last posted its earnings results on Tuesday, March 31st. The company reported ($287.24) earnings per share (EPS) for the quarter. The company had revenue of $1.42 million for the quarter. As a group, equities research analysts forecast that NewGenIvf Group will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d)” rating on shares of NewGenIvf Group in a research note on Monday, April 27th. One analyst has rated the stock with a Sell rating, According to MarketBeat, the stock presently has an average rating of “Sell”.

Insider Buying and Selling

In other NewGenIvf Group news, major shareholder Financial Lp Hrt sold 85,317 shares of NewGenIvf Group stock in a transaction on Wednesday, May 27th. The shares were sold at an average price of $0.80, for a total value of $68,253.60. Following the completion of the transaction, the insider owned 54,561 shares of the company’s stock, valued at approximately $43,648.80. The trade was a 60.99% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 31.80% of the company’s stock.

About NewGenIvf Group

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.